What is it about?
In this letter to the editor an example is shown why independent evaluation using fresh patient samples under real clinical conditions is vital for confirming the suitability and marketability of any new HbA1c assay.
Featured Image
Read the Original
This page is a summary of: Independent evaluation using fresh patient samples under real clinical conditions is vital for confirming the suitability and marketability of any new HbA1c assay. An example, Clinical Chemistry and Laboratory Medicine (CCLM), June 2018, De Gruyter,
DOI: 10.1515/cclm-2017-0930.
You can read the full text:
Contributors
The following have contributed to this page
